Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises iBinder Group in connection with the acquisition of Avima AB
Mandate

Vinge advises iBinder Group in connection with the acquisition of Avima AB

October 07, 2024 M&A Intellectual Property Corporate Commercial Employment and Benefits Corporate Tax IT, Telecommunications and Outsourcing

Avima AB is a Swedish specialist in project and information management, with expertise in complex projects within construction, real estate and infrastructure.

iBinder Group offers digital information management services for the construction and real estate industry. iBinder Group was founded in 2005 and the company helps clients increase productivity, reduce environmental impact and comply with laws and regulations in construction projects and real estate management.

Vinge’s team consisted of Johanna Wiberg, Johanna Hamrefält (Project Manager), Johan Gavelin (IP), Elis Allmark (Commercial/IT), Emelie Svanberg and Victor Ericsson (Tax), Jonna Skog (Employment) and Amelia Rihs (M&A).

Related

Vinge advises Right Side Group, a portfolio company of Alder, in connection with the acquisition of Brandkonsultbyrån i Sverige

 Brandkonsultbyrån in Sweden is a technical consultant specialising in structural fire protection, evacuation safety and risk management. The acquisition strengthens the group’s position as a leading player in fire, risk and safety in the Nordic region.
April 17, 2026

Vinge advises Vidia Climate Fund I in connection with the acquisition and acquisition financing of ABEKA El & Kraftanläggningar AB

 Vinge has acted as legal adviser to Vidia Climate Fund I in connection with the acquisition and acquisition financing of ABEKA El & Kraftanläggningar AB from Bravida and certain minority shareholders. ABEKA El & Kraftanläggningar AB is a highly specialized electrical grid services and project management provider.
April 17, 2026

Vinge adviser in the sale of SAGA Diagnostics

 Vinge acted as legal adviser relating to Swedish law in connection with the sale of SAGA Diagnostics to Roche’s subsidiary Foundation Medicine.
April 16, 2026